This collection was created to facilitate access to manuscripts published in Parasites & Vectors focusing on Credelio® Plus.
Credelio® Plus is an antiparasitic veterinary medicinal product containing a minimum dose of 20 mg/kg lotilaner and 0.75 mg/kg milbemycin oxime as active substances, which belong to the isoxazoline and macrocyclic lactones class of parasiticides, respectively. Credelio® Plus is administered monthly as an oral chewable tablet to dogs with, or at risk from, mixed infestations/infections of ticks, fleas, gastrointestinal nematodes, heartworm and/or lungworm.
The manuscripts in this collection contain data supporting the efficacy and safety of Credelio® Plus. All manuscripts have undergone the journals standard peer review process overseen by the Editors and each article can be found individually in the journal.
The studies presented in this collection and all journal charges for processing these manuscripts have been funded by Elanco Animal Health and a detailed conflict of interest is included within each article.